|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-09
|
$714,423
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
|
1R01CA227466-01
|
$699,062
|
ZIV, ELAD
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQ 5) Roles of mitochondrial heterogeneity in cell survival and oncogenesis
|
5R21CA216304-02
|
$195,750
|
NEWMEYER, DONALD
|
LA JOLLA INST FOR ALLERGY & IMMUNOLGY
|
|
(PQ#9): Altered mitochondrial transport and chemotherapy-induced peripheral neuropathy
|
5R21CA215985-02
|
$165,000
|
CHANG, KAREN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
(PQ1) Identifying and targeting human glioblastoma migrating in the peritumoral niche
|
5R01CA216054-02
|
$324,411
|
HAYDEN GEPHART, MELANIE
|
STANFORD UNIVERSITY
|
|
(PQ10) Harnessing the human gut microbiome to predict chemotherapy outcomes
|
1R21CA227232-01
|
$208,746
|
TURNBAUGH, PETER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQ3) Disruption of immune surveillance by aneuploidy and aberrant MHCII expression
|
5R01CA220009-02
|
$310,000
|
ZANETTI, MAURIZIO
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years
|
5R01CA206477-03
|
$791,933
|
PALEFSKY, JOEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
(PQ4) Quantitative and multiplexed analysis of gene function in cancer in vivo
|
1R01CA231253-01
|
$471,700
|
WINSLOW, MONTE
|
STANFORD UNIVERSITY
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
3R01CA208642-03S1
|
$71,387
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
3R01CA208642-03S2
|
$83,925
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Imaging mitochondrial heterogeneity in LKB1 mutant lung cancer
|
5R01CA208642-03
|
$352,275
|
SHACKELFORD, DAVID
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
|
1R01CA216101-01A1
|
$670,933
|
SHADEL, GERALD
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
|
5R01CA208735-02
|
$730,063
|
FELSHER, DEAN
|
STANFORD UNIVERSITY
|
|
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132379-09
|
$1,304,869
|
MARTINEZ, MARIA
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
16/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
|
5U01DK048443-25
|
$68,181
|
WATSON, KAROL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132384-09
|
$1,192,031
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
3-Dimensional profile of circulating miRNA for early cancer detection
|
5R01CA188991-04
|
$303,506
|
ZHONG, WENWAN
|
UNIVERSITY OF CALIFORNIA RIVERSIDE
|
|
3/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
|
1U54CA233465-01
|
$1,141,251
|
CARPTEN, JOHN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
3D Dynamic Contrast-Enhanced US for Monitoring Chemotherapy of Liver Metastasis
|
5R01CA195443-03
|
$208,861
|
KAMAYA, AYA
|
STANFORD UNIVERSITY
|
|
A 3D Model of the Perivascular Niche to Investigate Glioblastoma Invasion
|
1F31CA228317-01
|
$39,703
|
WOLF, KAYLA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A biophysical stromal basis for radiation sensitivity in ductal carcinoma in situ
|
5R01CA174929-05
|
$570,235
|
PARK, CATHERINE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A blood test to identify prostate cancer patients at risk for visceral metastasis
|
5R01CA218356-02
|
$601,750
|
POSADAS, EDWIN
|
CEDARS-SINAI MEDICAL CENTER
|
|
A Clinical Center to Study Immunological and Hormonal Biomarkers for the Diagnosis, Prediction and Treatment of Chronic Pancreatitis and its associated development to Diabetes and Pancreas Cancer
|
5U01DK108300-04
|
$190,000
|
PARK, WALTER
|
STANFORD UNIVERSITY
|
|
A clones genomic stability as biomarker of its DNA-damage resilience
|
5K99CA215256-02
|
$166,644
|
ANDOR, NOEMI
|
STANFORD UNIVERSITY
|
|
A collaborative structural hub to promote Cancer Center science and drug design
|
5R50CA211440-03
|
$145,562
|
ALESHIN, ALEXANDER
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
A functional genomics approach to determine the mechanism of cellular response to new anti-cancer
|
5R00CA204602-03
|
$249,000
|
GILBERT, LUKE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Genetic Toolbox for the Identification and Interrogation of Tumor Cells of Origin, Propagation, and Recurrence From Patient-derived Oncogenic Drivers
|
5R33CA202900-03
|
$418,127
|
BREUNIG, JOSHUA
|
CEDARS-SINAI MEDICAL CENTER
|
|
A high content screen dissecting ciliogenesis and oncogenic Hedgehog signaling
|
5R01CA181231-03
|
$488,144
|
REITER, JEREMY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia
|
5R01CA190843-04
|
$311,458
|
SOHN, LYDIA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A Microfluidics Approach to Investigate Tumor Cell Trafficking in Bone Marrow
|
5F32CA210540-02
|
$61,174
|
GLASER, DREW
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
A model for predicting response to PD-1 inhibitors in NSCLC
|
5R01CA208403-02
|
$635,258
|
GARON, EDWARD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Multimedia Self-Management Intervention to Prepare Family Caregivers and Patients for Lung Cancer Surgery
|
1R01CA217841-01A1
|
$717,367
|
SUN, VIRGINIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A nanosystem for tumor treatment and imaging
|
5R01CA188883-05
|
$404,625
|
RUOSLAHTI, ERKKI
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
A new class of CSF-1R radioligands for monitoring glioblastoma progression and therapy
|
5R21CA205564-02
|
$171,060
|
CHIN, FREDERICK
|
STANFORD UNIVERSITY
|
|
A New Mechanism for Castration Resistant Prostate Cancer
|
5R01CA166894-06
|
$368,984
|
SUN, ZIJIE
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Novel Anti-HER2/neu IgE for Breast Cancer Therapy
|
5R01CA181115-05
|
$592,761
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Novel PET Probe for Use in Cancer Diagnostics
|
5R44CA216539-03
|
$999,412
|
MOORE, MELISSA
|
SOFIE BIOSCIENCES, INC.
|
|
A novel point of care test for oral and oropharyngeal cancer risk
|
5R01CA204264-02
|
$554,293
|
CALIFANO, JOSEPH
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease
|
5R01CA201719-03
|
$361,510
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL
|
5R01CA196266-03
|
$860,660
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
3R21CA205106-02S1
|
$77,331
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
5R21CA205106-02
|
$176,605
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A pan-cancer role for MutL loss in inducing treatment resistance
|
1K22CA229613-01
|
$147,169
|
HARICHARAN, SVASTI
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
A Patient-Centered Approach to Integration of Life Expectancy into Treatment Decision Making for Patients with Genitourinary Malignancy
|
1K08CA230155-01
|
$183,258
|
DASKIVICH, TIMOTHY
|
CEDARS-SINAI MEDICAL CENTER
|
|
A Phase I Study of Intracranially Administered Carboxylesterase-Expressing Neural Stem Cells in Combination with Intravenous Irinotecan in Patients with Recurrent High Grade Gliomas
|
5R01CA198076-04
|
$546,873
|
PORTNOW, JANA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A Phase II trial of abiraterone in combination with PDMX1001 in enzalutamide-resistant prostate cancer
|
2R44CA206668-02A1
|
$754,319
|
LIU, CHENGFEI
|
PANDOMEDX, INC.
|
|
A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors
|
5R01CA200977-03
|
$639,777
|
GANZ, PATRICIA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Prototype Stationary X-Ray Source Digital Breast Tomosynthesis System
|
5R01CA214515-02
|
$349,610
|
SCHWOEBEL, PAUL
|
SRI INTERNATIONAL
|
|
A Quantitative Multiplexed Platform for the Pharmacogenomic Analysis of Lung Cancer
|
5R01CA207133-03
|
$554,387
|
WINSLOW, MONTE
|
STANFORD UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|